Biora Therapeutics, Inc. (BIORQ) vs Eocene Ltd. (EOCN)

Biora Therapeutics, Inc. and Eocene Ltd. are both Biotechnology companies. Biora Therapeutics, Inc. and Eocene Ltd. are of similar size ($2.6M and $2.5M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against 87.8%. Eocene Ltd. has the higher net margin (0.00% vs −3,527.9%) and the lower return on invested capital (−163.2% vs 0.00%). Across the 15 metrics below, Biora Therapeutics, Inc. leads on 8 and Eocene Ltd. on 7.

Valuation

Metric BIORQ EOCN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.28 9.40
P/B n/m 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.63 0.66
EV/Sales 67.44 (3.06) 9.02
Earnings yield 0.00% (518.42%) (32.88%)
Free cash flow yield 0.00% (327.63%) (23.13%)

Profitability

Metric BIORQ EOCN Biotechnology median
Gross margin 85.79% 0.00% 68.51%
Operating margin (6,809.06%) 0.00% 0.00%
Net margin (3,527.85%) 0.00% 0.00%
Free cash flow margin (5,165.88%) 0.00% 0.00%
Return on equity 27.98% (68.21%) (51.96%)
Return on assets (128.19%) (55.03%) (46.06%)
Return on invested capital 0.00% (163.19%) 0.00%

Growth

Metric BIORQ EOCN Biotechnology median
Revenue growth (TTM) 347.00% 87.83% 6.76%
EPS growth (last fiscal year) (57.40%) 70.42% 29.88%
Revenue growth, 5-year CAGR (87.44%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ EOCN Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 4.16 4.97
Net debt to EBITDA (0.47) 1.31 1.01

Dividend

Metric BIORQ EOCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIORQ EOCN Biotechnology median
Market cap 2.49m 2.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack